DGX Quest Diagnostics Loading...

From LH earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
13:00
Apr 30 ◎
Adam Schechter CEO, Labcorp Holdings Inc. LH Q1 FY26 call
Management expects the pipeline of hospital and regional lab deals to strengthen if PAMA goes into effect in January, as smaller labs will struggle to compete with scale players like LabCorp. — PAMA implementation could accelerate consolidation in the lab industry, benefiting large-scale players like LabCorp and Quest Diagnostics.
DGX
MED

About DGX Analyst Coverage

Buzzberg tracks DGX (Quest Diagnostics) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Adam Schechter.